艾格里房产(ADC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADC 艾格里房产

休市中 11-13 16:00:00 EST

69.37

+0.27

+0.39%

盘后69.37

+0.000.00%

19:30 EST

最高69.59	最低68.89	成交量192.63万
今开69.47	昨收69.10	日振幅1.01%
总市值90.25亿	流通市值88.68亿	总股本1.30亿
成交额1.34亿	换手率1.51%	流通股本1.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"艾格里房产","latestPrice":69.37,"timestamp":1794603600000,"preClose":69.1,"halted":0,"volume":1926342,"hourTrading":{"tag":"盘后","latestPrice":69.37,"preClose":69.37,"latestTime":"19:30 EST","volume":440170,"amount":30534541.485,"timestamp":1794616206697,"change":0,"changeRate":0,"amplitude":0.001297},"delay":0,"changeRate":0.00390738060781491,"floatShares":127832949,"shares":130101000,"eps":1.939623,"marketStatus":"休市中","change":0.27,"latestTime":"11-13 16:00:00 EST","open":69.465,"high":69.59,"low":68.89,"amount":133501915.31886,"amplitude":0.01013,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.939623,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":69.1,"dividendRate":0.045755,"preHourTrading":{"tag":"盘前","latestPrice":69.7166,"preClose":69.1,"latestTime":"09:28 EST","volume":36,"amount":2502.55098,"timestamp":1794580127511,"change":0.6166,"changeRate":0.008923,"amplitude":0.007476},"postHourTrading":{"tag":"盘后","latestPrice":69.37,"preClose":69.37,"latestTime":"19:30 EST","volume":440170,"amount":30534541.485,"timestamp":1794616206697,"change":0,"changeRate":0,"amplitude":0.001297},"volumeRatio":1.1804347345213542,"impliedVol":0.2283,"impliedVolPercentile":0.49},"requestUrl":"/m/hq/s/ADC","defaultTab":"news","newsList":[{"id":"2683356586","title":"新版医保目录新增51个一类新药，CAR-T首进，还有哪些亮点？","url":"https://stock-news.laohu8.com/highlight/detail?id=2683356586","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683356586?lang=zh_cn&edition=full","pubTime":"2026-11-14 19:54","pubTimestamp":1794657259,"startTime":"0","endTime":"0","summary":"11月14日，2026创新药高质量发展大会在苏州举办，2026版基本医保药品目录和创新药目录（简称“双目录”）也在本次大会正式发布。尽管苏州的天气是阴沉的，大会现场气氛却十分热烈。澎湃新闻记者注意到，大会安排了超过1500个的座位，座无虚席，也有不少参会者选择站着听会。根据国家医保局发布的消息，基本医保目录新增107种药品，其中51个一类新药，再创历史新高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611143931362664.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611143931362664.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4022","BK1161","ADC","MEDX","NETL","BK4230","CD","BK4080","BK4195","BK4023","PFS","BK1574","BK4116","BK4211","UCB","CAR","BK4231","LNGR","IBBQ","06978","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681815717","title":"浦东数字贸易向全球递出“新名片”：系统推进国家数字贸易示范区建设，目标2030年总额达780亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681815717","media":"浦东发布","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681815717?lang=zh_cn&edition=full","pubTime":"2026-11-07 11:18","pubTimestamp":1794021480,"startTime":"0","endTime":"0","summary":"今年8月，商务部印发国家数字贸易示范区首批创建名单，全国共24家单位入选，浦东新区作为上海唯一入选单位上榜。根据创建工作方案，浦东将围绕制度开放、主体培育、出海服务、治理机制四大方向，系统推进国家数字贸易示范区建设——力争到2027年底，数字贸易总额超过660亿美元；到2028年底，超过700亿美元；到2030年底，力争迈上780亿美元台阶。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-11-07/doc-inixwnye4893055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BD","BK4080","ADC","NETL","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681957468","title":"大健康行业创新成果集中亮相","url":"https://stock-news.laohu8.com/highlight/detail?id=2681957468","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681957468?lang=zh_cn&edition=full","pubTime":"2026-11-07 00:31","pubTimestamp":1793982660,"startTime":"0","endTime":"0","summary":"在第九届中国国际进口博览会（以下简称“进博会”）的医疗器械及医药保健展区，一批中国创新成果集中亮相，成为一大看点。《证券日报》记者在进博会现场注意到，与往年集中展示各大企业的全球创新药械成果相比，今年各大跨国药企的展台似乎都在强调与中国的“双向创新”。摩根大通中国区医疗健康投资银行主管邬峥在接受记者采访时表示，中国本土创新能力的提升，正在为跨国药企带来新的合作机会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611073925241467.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611073925241467.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["MEDX","BK4231","BK4080","LNGR","NETL","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681882278","title":"90后，她一战回报400亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2681882278","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681882278?lang=zh_cn&edition=full","pubTime":"2026-11-06 09:16","pubTimestamp":1793927786,"startTime":"0","endTime":"0","summary":"投资界获悉，11月4日中国生物制药宣布与德国药企勃林格殷格翰达成授权合作，潜在交易金额高达70亿美元。如今，勃林格殷格翰最高70亿美元的新交易接踵而至。数据显示，今年前三季度，我国创新药累计获批60款，对外授权交易总额超过1300亿美元，已达到去年全年水平。算上该笔交易，中国生物制药年内国际授权潜在总金额已突破百亿美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1793840783771396172","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4588","BK4080","BK4585","KCE","CALF","BK4231","NETL","MYLD","ADC","XMMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679243824","title":"2026年10月30日“大众30”成份股报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2679243824","media":"大众证券报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679243824?lang=zh_cn&edition=full","pubTime":"2026-10-30 22:24","pubTimestamp":1793370240,"startTime":"0","endTime":"0","summary":"本报综合消息 本周，大盘呈现震荡探底的走势，上证指数下跌2.48%，深证成指下跌7.20%，创业板指下跌10.08%，大众30指数上涨0.09%。大众30指数成分股中，位居本周涨幅前五位的股票是百普赛斯、义翘神州、中远海控、中国石化、青岛银行，涨幅分别为17.51%、13.28%、12.56%、9.87%、9.25%;跌幅榜上，鼎通科技、凌云光、蓝特光学等跌幅居前。今年前三季度，百普赛斯实现营收80064.33万元，同比增长30.61%;净利润16158.51万元，同比增长22.02%。30指数回顾“大众30”成分股每日报告","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-30/doc-iniwzprn2164264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399001","BK4080","BK4231","ADC","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678149129","title":"九大研究贯通两大板块：艾帕洛利托沃瑞利单抗以全病程布局回应消化道肿瘤之困","url":"https://stock-news.laohu8.com/highlight/detail?id=2678149129","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678149129?lang=zh_cn&edition=full","pubTime":"2026-10-27 16:13","pubTimestamp":1793088780,"startTime":"0","endTime":"0","summary":"  编者按：2026年欧洲肿瘤内科学会(ESMO)年会于10月23日至27日在西班牙马德里召开，作为全球肿瘤领域最具影响力的学术盛会之一，ESMO始终聚焦前沿诊疗进展，引领临床实践变革方向。本届年会 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261027/c681134750.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261027/c681134750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["CBTJ","BTCW","CBXY","BAGY","HODL","SD","FBTC","ADC","CBOO","CBTY","PFS","BITU","BTF","BTCI","BCCC","CBXO","CBOJ","BPI","BTCC","HPEL","GBTC","BTCL","PXI","MSS","IBIT","BTCO","BTRN","HPE","XBTY","NETL","ORR","CBOY","CR","BITX","BITY","BTC","CBXA","PR","L","MNRS","BITO","BFJL","MAXI","BFAP","CBXJ","CBOA","YBTC","FXN","BETH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678192753","title":"默沙东ADC药物降低晚期子宫内膜癌患者死亡风险32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678192753","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678192753?lang=zh_cn&edition=full","pubTime":"2026-10-26 23:39","pubTimestamp":1793029155,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4080","NETL","BK4231","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678935411","title":"CLARITY-Gastric01 试验显示，Sone-Ve治疗二线及后线的 CLDN18.2 表达的晚期胃癌/胃食管结合部癌患者可降低死亡风险达 42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678935411","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678935411?lang=zh_cn&edition=full","pubTime":"2026-10-26 19:06","pubTimestamp":1793012760,"startTime":"0","endTime":"0","summary":"Sone-Ve在主要终点中使三线及以后治疗患者的死亡风险降低 53%。作为首个在该治疗人群中显示生存获益的CLDN18.2靶向疗法，Sone-Ve相比于对照组，将中位生存期延长了四个多月，有望改变CLDN18.2表达患者的治疗格局。关于胃癌与胃食管结合部癌 胃癌是全球第五大常见癌症，也是第五大癌症相关死亡原因。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5080677_ZH80677_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5080677_ZH80677_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["PFS","BAGY","BITY","BTCC","SBIT","CBTO","CBOO","CBTJ","CBOA","CBXO","DFII","BTC","CBXJ","COAL","IBBQ","AZN","TRAE","HCC","HODL","CBOY","BRRR","CBXA","BPI","CBTA","FBTC","BTF","BITB","BCCC","BETH","CBTY","BITU","MAXI","EZBC","ADC","XBTY","BTRN","BTCZ","MNRS","CBXY","DEFI","GBTC","BITO","BTCL","YBTC","AZNH","EAC","CBOJ","BTCO","NETL","BTCW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678370601","title":"生存期翻倍！阿斯利康胃癌新药sone-ve剑指50亿美元年销，ADC取代化疗再进一步","url":"https://stock-news.laohu8.com/highlight/detail?id=2678370601","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678370601?lang=zh_cn&edition=full","pubTime":"2026-10-26 09:20","pubTimestamp":1792977603,"startTime":"0","endTime":"0","summary":"阿斯利康为这款全名为sonesitatug vedotin的药物设定的潜在年销售额预期为30亿至50亿美元。在这项研究中，接受旧药治疗的患者因副作用而退出的比例高于sone-ve组，而与治疗相关的死亡人数大致相当。在另一组胃癌患者人群中，武田制药的arcotatug tavatecan帮助受试者多存活了3个多月，相关数据在本次大会上公布。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["ADC","NETL","BK4080","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678213384","title":"2026年欧洲肿瘤内科学会召开：32项中国相关研究入选突破性摘要 占总入选数逾三成","url":"https://stock-news.laohu8.com/highlight/detail?id=2678213384","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678213384?lang=zh_cn&edition=full","pubTime":"2026-10-25 19:41","pubTimestamp":1792928460,"startTime":"0","endTime":"0","summary":"当地时间10月23日，全球肿瘤学领域最具影响力的学术会议之一2026年欧洲肿瘤内科学会（ESMO）年会在西班牙马德里举行。本届大会上，中国创新药表现受到关注。据爱建证券有限责任公司（以下简称“爱建证券”）的研报统计，在本届大会的最新突破性摘要（LBA）名单中，中国相关研究达到32项，占比超过三成（共96项LBA）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610253907268231.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610253907268231.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1587","BK4139","TIL","BD","BK4080","BK4231","00013","BK1588","ADC","BK4505","KURE","BK1191","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677276908","title":"CLDN18.2靶向ADC 3期研究达到双主要终点；双靶点ADC 3期结果积极……","url":"https://stock-news.laohu8.com/highlight/detail?id=2677276908","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677276908?lang=zh_cn&edition=full","pubTime":"2026-10-24 07:35","pubTimestamp":1792798500,"startTime":"0","endTime":"0","summary":" CLDN18.2靶向ADC国际3期研究达到双主要终点，延长胃癌患者PFS和OS 武田(Takeda)和信达生物(Innovent Biologics)公布了在研CLDN18.2靶向抗体偶联药物(ADC)arcotatug tava ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261024/c681047440.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261024/c681047440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU0321505868.SGD","ITT","LU0237698245.USD","IE00BSNM7G36.USD","BK4139","LU1670710661.SGD","LU1670711123.USD","BK4585","FTXH","LU2360032135.SGD","LU1430594728.SGD","BK4532","LU1074936037.SGD","NETL","BMY","LU0456855351.SGD","BK4559","LU1571399168.USD","BK4534","LU2596442595.SGD","ORR","BK4211","LU2133065610.SGD","IE00BFXG1179.USD","LU0225284248.USD","LU0306806265.USD","LU0432979614.USD","LU1236620750.USD","LU0061475181.USD","GMAB","LU2242646821.SGD","BK4195","LU0096364046.USD","LU1261432733.SGD","IHE","BK4231","LU1032466523.USD","BK4581","PFS","IE0009355771.USD","LU1983299246.USD","LU1868837136.USD","LU2125154935.USD","LU0985481810.HKD","FFBC","LU1291159041.SGD","LU1670711040.USD","LU0114720955.EUR","ADC","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677932937","title":"不限癌种！优赫得泛肿瘤适应症在华获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2677932937","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677932937?lang=zh_cn&edition=full","pubTime":"2026-10-22 15:41","pubTimestamp":1792654860,"startTime":"0","endTime":"0","summary":"南方财经10月22日电，阿斯利康今日宣布，由阿斯利康和第一三共共同开发与商业化的优赫得?（英文商品名：Enhertu?，通用名：注射用德曲妥珠单抗）于2026年10月20日正式获得中国国家药品监督管理局（NMPA）批准，单药适用于治疗既往接受过治疗或无满意替代治疗方案的不可切除或转移性HER2表达为IHC3+的成人实体瘤患者。该适应症是基于单臂临床试验的结果给予的附条件批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610223904083542.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610223904083542.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4231","BK4080","ADC","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154809345","title":"财报前瞻 | 艾格里房产本季营收预计增17.46%，机构观点偏积极","url":"https://stock-news.laohu8.com/highlight/detail?id=1154809345","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154809345?lang=zh_cn&edition=full","pubTime":"2026-10-13 08:38","pubTimestamp":1791851938,"startTime":"0","endTime":"0","summary":"艾格里房产将于2026年10月20日发布季度财报，市场关注租金规模与融资策略对营收与每股收益的提振幅度及其延续性。市场一致预期本季度艾格里房产营收为2.09亿美元，同比增长17.46%；调整后每股收益为0.48美元，同比增长5.78%；息税前利润为1.09亿美元，同比增长26.27%，公司与卖方渠道尚未披露本季度毛利率、净利率或净利润预测。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 | 艾格里房产本季营收预计增17.46%，机构观点偏积极","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674854284","title":"盟科药业(688373.SH)拟与ClearideBio签订授权许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2674854284","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674854284?lang=zh_cn&edition=full","pubTime":"2026-10-09 20:52","pubTimestamp":1791550369,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4231","ADC","BK4080","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669964109","title":"乐普生物(02157.HK)：CMG901(AZD0901)临床研究结果入选LBA并将于主席研讨会上公布 总计4项临床研究结果入选2026年ESMO大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2669964109","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669964109?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:36","pubTimestamp":1790152598,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ADC","BK4231","LU0266512127.USD","LU0456854461.SGD","BK4080","CRC","BK4213","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198015374","title":"艾格里房产公司——净收益将用于公司运营、债务削减、收购及开发项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1198015374","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198015374?lang=zh_cn&edition=full","pubTime":"2026-09-18 04:06","pubTimestamp":1789675570,"startTime":"0","endTime":"0","summary":"艾格里房产公司近日宣布，其预计获得的净收益将主要用于公司日常运营、债务削减、潜在收购以及房地产开发等方向。通过此番资本配置策略，艾格里房产旨在平衡短期财务稳健性与长期战略布局，从而为股东创造持续价值。未来，随着资金逐步到位，艾格里房产的运营灵活性有望得到进一步提升，而债务压力的缓解也将为其后续扩张提供更坚实的财务基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","NETL","ADC","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667367005","title":"优赫得一线治疗HER2突变晚期非鳞状NSCLC中位PFS达14.3个月","url":"https://stock-news.laohu8.com/highlight/detail?id=2667367005","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667367005?lang=zh_cn&edition=full","pubTime":"2026-09-16 14:05","pubTimestamp":1789538700,"startTime":"0","endTime":"0","summary":"9月14日，国际肺癌研究协会2026世界肺癌大会正在召开。会上，阿斯利康和第一三共公布了代号为DESTINY-Lung04的III期临床研究结果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609163875988974.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609163875988974.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4080","BK4231","ADC","BK4195","NETL","PFS","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667466104","title":"CRO板块强势走高！多家CRO上市公司解密业务近况","url":"https://stock-news.laohu8.com/highlight/detail?id=2667466104","media":"微博财经-财道工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667466104?lang=zh_cn&edition=full","pubTime":"2026-09-14 21:08","pubTimestamp":1789391280,"startTime":"0","endTime":"0","summary":"在互动平台与机构调研中，多家具备CRO业务的上市公司近期密集回应市场关切，披露了订单、产能及全球化布局的最新进展。2026 年上半年，公司实现 CRO 销售收入 4,513.95 万元， 较上年同期增长 10.91%。截至 2026 年上半年末，客户群体不断扩大，累计服务超过 16,900 家研发实验室客户。CRO 业务毛利率基本保持相对稳定水平，具体受服务类型、项目内容影响有所波动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2026-09-14/doc-inirveaq9305051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","NETL","06978","BK4231","LNGR","MEDX","IBBQ","BK4080","ADC","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665062393","title":"一个还没进临床的分子，凭什么卖出12.95亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665062393","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665062393?lang=zh_cn&edition=full","pubTime":"2026-09-07 10:08","pubTimestamp":1788746914,"startTime":"0","endTime":"0","summary":"对一款尚未进入人体临床试验的资产而言，1.1亿美元的首付款属于明显偏高的定价。2023年，和黄医药将已在中国获批上市的呋喹替尼授权给武田制药：总额11.3亿美元，首付款4亿美元。那是\"成熟产品出海\"的典范，一个经过临床验证、获批上市的分子，换取全球市场权益。HMPL-A830尚未启动I期临床，和黄医药卖的是一个\"概念验证前\"的平台资产，而12.95亿美元的总交易额，已经超过了呋喹替尼的11.3亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788491648644278418","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["KURE","BK1191","BK4080","BK4231","BK1588","00013","ADC","NETL","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663046879","title":"礼来上半年营收427.73亿美元，替尔泊肽占比65%近277亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663046879","media":"经济参考网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663046879?lang=zh_cn&edition=full","pubTime":"2026-08-30 12:16","pubTimestamp":1788063391,"startTime":"0","endTime":"0","summary":"近日，礼来（EliLillyandCompany，NYSE：LLY）公布2026年上半年及第二季度业绩。财报显示，今年上半年，礼来实现总营收427.73亿美元，同比增长49%。其中第二季度营收达229.74亿美元，同比增长48%，超市场预期。基于上半年的强劲增长势头，礼来将2026年全年营收指引从此前的820亿至850亿美元上调至850亿至870亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608303859354883.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608303859354883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4080","LU0244354667.USD","BK1589","BK1583","LU2097828631.EUR","LU2488822045.USD","01801","LU2242644610.SGD","LU1188198961.HKD","NETL","LU1969619763.USD","LU2097828474.EUR","LU0455707207.USD","LU0326950275.SGD","LU2328871848.SGD","BK1161","BK4022","BK4231","BK4230","ADC","LU2097828805.USD","LU0502904849.HKD","LU2097828557.USD","LU0463099449.HKD","HK0000165453.HKD","CAR","LU2097828714.EUR","KURE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agreerealty.com","stockEarnings":[{"period":"1week","weight":-0.0072},{"period":"1month","weight":0.0578},{"period":"3month","weight":-0.0718},{"period":"6month","weight":-0.0684},{"period":"1year","weight":-0.0588},{"period":"ytd","weight":-0.0369}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Agree Realty Corporation成立于1971年，是马里兰州的一家公司。该公司是一家完全整合的房地产投资信托基金，主要专注于净出租给行业领先租户的零售物业的所有权、收购、开发和管理。","yearOnYearQuotes":[{"month":1,"riseRate":0.59375,"avgChangeRate":-0.003579},{"month":2,"riseRate":0.46875,"avgChangeRate":0.002186},{"month":3,"riseRate":0.5625,"avgChangeRate":0.012831},{"month":4,"riseRate":0.59375,"avgChangeRate":0.003425},{"month":5,"riseRate":0.484848,"avgChangeRate":0.013996},{"month":6,"riseRate":0.666667,"avgChangeRate":0.010466},{"month":7,"riseRate":0.666667,"avgChangeRate":0.022977},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.000027},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.008411},{"month":10,"riseRate":0.575758,"avgChangeRate":-0.000211},{"month":11,"riseRate":0.666667,"avgChangeRate":0.004515},{"month":12,"riseRate":0.46875,"avgChangeRate":0.00994}],"exchange":"NYSE","name":"艾格里房产","nameEN":"Agree"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾格里房产(ADC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾格里房产(ADC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾格里房产,ADC,艾格里房产股票,艾格里房产股票老虎,艾格里房产股票老虎国际,艾格里房产行情,艾格里房产股票行情,艾格里房产股价,艾格里房产股市,艾格里房产股票价格,艾格里房产股票交易,艾格里房产股票购买,艾格里房产股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾格里房产(ADC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾格里房产(ADC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}